CA2063791A1 - Capsule de gelatine dure renfermant des nutriments liposolubles - Google Patents

Capsule de gelatine dure renfermant des nutriments liposolubles

Info

Publication number
CA2063791A1
CA2063791A1 CA2063791A CA2063791A CA2063791A1 CA 2063791 A1 CA2063791 A1 CA 2063791A1 CA 2063791 A CA2063791 A CA 2063791A CA 2063791 A CA2063791 A CA 2063791A CA 2063791 A1 CA2063791 A1 CA 2063791A1
Authority
CA
Canada
Prior art keywords
fat
soluble
containing fat
capsule containing
soluble nutrients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2063791A
Other languages
English (en)
Other versions
CA2063791C (fr
Inventor
Michael John Story
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PII Drug Delivery LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898918809A external-priority patent/GB8918809D0/en
Application filed by Individual filed Critical Individual
Publication of CA2063791A1 publication Critical patent/CA2063791A1/fr
Application granted granted Critical
Publication of CA2063791C publication Critical patent/CA2063791C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

Capsules dures de gélatine contenant: (a) un nutriment soluble dans la matière grasse, tel qu'une vitamine (A, D, E ou K) soluble dans de la matière grasse ou un glycéride d'acide gras insaturé; (b) un tensio-actif non ionique tel qu'une huile de ricin polyoxyéthylée (facultativement hydrogénée), et/ou un polyéthylène glycol; (c) un agent adoucissant la gélatine tel que le glycérol, le propylène glycol ou, de préférence, du mono-oléate de glycéryle; et facultativement (d) de l'eau. Ainsi, on réduit ou on évite les problèmes de fragilité rencontrés habituellement avec les capsules dures de gélatine contenant des nutriments solubles dans la matière grasse.
CA002063791A 1989-08-17 1990-08-17 Capsule de gelatine dure renfermant des nutriments liposolubles Expired - Lifetime CA2063791C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB898918809A GB8918809D0 (en) 1989-08-17 1989-08-17 Pharmaceutical formulations
GB8918809.8 1989-08-17
PCT/GB1990/001299 WO1991002520A1 (fr) 1989-08-17 1990-08-17 Compositions pharmaceutiques
US08/430,500 US5738871A (en) 1989-08-17 1995-04-28 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
CA2063791A1 true CA2063791A1 (fr) 1991-02-18
CA2063791C CA2063791C (fr) 2000-12-19

Family

ID=26295779

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002063791A Expired - Lifetime CA2063791C (fr) 1989-08-17 1990-08-17 Capsule de gelatine dure renfermant des nutriments liposolubles

Country Status (13)

Country Link
US (1) US5738871A (fr)
EP (1) EP0487575B1 (fr)
JP (1) JPH04507418A (fr)
AT (1) ATE113471T1 (fr)
AU (1) AU633959B2 (fr)
CA (1) CA2063791C (fr)
DE (1) DE69013923T2 (fr)
DK (1) DK0487575T3 (fr)
ES (1) ES2062543T3 (fr)
FI (1) FI920646A0 (fr)
HK (1) HK85196A (fr)
NO (1) NO302333B1 (fr)
WO (1) WO1991002520A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
SI1033128T2 (sl) 1993-09-28 2012-02-29 Scherer Gmbh R P Izdelava mehke Ĺľelatinaste kapsule
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
ATE199481T1 (de) * 1995-11-24 2001-03-15 Loders Croklaan Bv Zusammensetzung auf basis von fischöl
US6056971A (en) * 1996-07-24 2000-05-02 Biosytes Usa, Inc. Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AUPP022297A0 (en) * 1997-11-06 1997-11-27 R.P. Scherer Holdings Pty Ltd Vitamin coating
TW367247B (en) * 1998-02-03 1999-08-21 Otsuka Pharma Co Ltd Storage container for Vitamin D solution and transfusion container
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
US6346231B1 (en) * 1999-10-06 2002-02-12 Joar Opheim Flavored gelatin capsule and method of manufacture
US6365181B1 (en) 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition
GB0101198D0 (en) 2001-01-17 2001-02-28 Scherer Technologies Inc R P Ingestible compositions containing an odoriferous oil
AUPR510001A0 (en) * 2001-05-18 2001-06-14 Jupitar Pty Ltd Formulation and method
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
EP1499303A4 (fr) * 2002-04-10 2007-07-25 Fred H Miller Systeme capsulaire a plusieurs compartiments et plusieurs phases
EP1589930A2 (fr) * 2003-01-08 2005-11-02 Flacco-Nesselroad Family Trust Therapie combinee anticoagulante
JP2005075804A (ja) * 2003-09-03 2005-03-24 Toyo Capsule Kk メナテトレノン含有医薬組成物
JPWO2005089716A1 (ja) * 2004-03-24 2008-01-31 武田薬品工業株式会社 高含量化製剤
US20050232981A1 (en) 2004-04-15 2005-10-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
US20080044538A1 (en) * 2004-08-31 2008-02-21 Akzo Nobel N.V. Method For Pigment Solubilization, A pigment Composition And Its Use
MX2009000118A (es) * 2006-06-27 2009-01-26 Akzo Nobel Nv Formulaciones que comprenden una vitamina y el uso de las mismas para elaborar alimento fortificado para animales y formulaciones para el cuidado personal.
EP2214481B1 (fr) 2007-10-15 2019-05-01 United Animal Health, Inc. Procédé permettant d'accroître la performance d'une progéniture
JP6063615B2 (ja) * 2008-04-29 2017-01-18 株式会社日健総本社 眼の医学的症状の治療用組成物
WO2009133552A2 (fr) 2008-04-29 2009-11-05 Nikken Sohonsha Corporation Procédés de traitement de troubles ophtalmiques
EP2343982B1 (fr) 2008-09-17 2017-03-22 Chiasma Inc. Préparations pharmaceutiques et méthodes associées d'administration
PH12019500030A1 (en) 2009-03-09 2020-02-10 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
US8197871B2 (en) * 2009-05-13 2012-06-12 L Europa Gary A Composition for headache treatment
EP2490678B1 (fr) * 2009-10-23 2021-08-04 Basf As Capsules ou comprimés enrobés d'un mélange oléagineux d'acides gras
US10610528B2 (en) * 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
EP2613652B1 (fr) 2010-09-07 2016-10-26 DSM Nutritional Products AG Émulsions comestibles
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
US8715648B2 (en) 2011-02-16 2014-05-06 Pivotal Therapeutics Inc. Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
JP6618488B2 (ja) 2014-06-17 2019-12-11 メルク・シャープ・エンド・ドーム・ベー・フェー テストステロンウンデカノエートの安定な製剤
CA2975599A1 (fr) 2015-02-03 2016-08-11 Chiasma Inc. Methode de traitement de maladies
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
DE102021003906B4 (de) 2021-07-30 2023-03-30 Mirco Bienhaus Verfahren und Vorrichtungen zur Herstellung fester oder halbfester Arzneiformen mit einem mehrschichtigen Aufbau

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5665820A (en) * 1979-11-02 1981-06-03 Eisai Co Ltd Hard capsule with high content of tocopherol nicotinate
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
AU561367B2 (en) * 1983-05-02 1987-05-07 Scherer, R.P. Pty. Ltd. Vitamin composition with enhanced bioavailability
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
JPH01233218A (ja) * 1988-03-15 1989-09-19 Daikyo Yakuhin Kogyo Kk ビタミン組成物
US5188688A (en) * 1990-07-20 1993-02-23 Minnesota Mining And Manufacturing Company Method of sealing a gelatin capsule
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations

Also Published As

Publication number Publication date
ES2062543T3 (es) 1994-12-16
NO920604D0 (no) 1992-02-14
CA2063791C (fr) 2000-12-19
DK0487575T3 (da) 1994-11-28
NO302333B1 (no) 1998-02-23
AU633959B2 (en) 1993-02-11
FI920646A0 (fi) 1992-02-14
NO920604L (no) 1992-02-14
JPH04507418A (ja) 1992-12-24
US5738871A (en) 1998-04-14
HK85196A (en) 1996-05-24
EP0487575B1 (fr) 1994-11-02
DE69013923D1 (de) 1994-12-08
ATE113471T1 (de) 1994-11-15
EP0487575A1 (fr) 1992-06-03
WO1991002520A1 (fr) 1991-03-07
AU6161990A (en) 1991-04-03
DE69013923T2 (de) 1995-03-16

Similar Documents

Publication Publication Date Title
CA2063791A1 (fr) Capsule de gelatine dure renfermant des nutriments liposolubles
EP0165352A3 (fr) Solutions micellaires liquides d'agents nutritifs essentiels oléosolubles
GR980300014T1 (en) New galenic formulations containing fenofibrate and their applications
ES534598A0 (es) Un procedimiento para preparar una solucion acuosa que contiene una sustancia farmaceutica soluble en lipidos
AR004483A1 (es) Compuestos para uso en terapia que comprenden un residuo de 1,3-propano diol como agente enlazante entre el residuo de ácido graso y un residuo bioactivo, usos de dichos compuestos y medicamentos , alimentos y formulaciones para el cuidado o tratamiento de la piel que comprenden a dichos compuestos
AU7423794A (en) Soft gelatin capsule manufacture
DE3580236D1 (de) Ibuprofen enthaltende weichgelatinekapseln und verfahren zu ihrer herstellung.
CA2225797A1 (fr) Vehicules de principes actifs a base de tensioactifs non ioniques et leurs applications notamment dans les domaines alimentaire, cosmetique et pharmaceutique
EP0384547A3 (fr) Compositions de graisses alimentaires, résistant à l'oxydation et contenant un agent anti-oxydant actif, extraites de tissus végétaux
MY104412A (en) Acne treatment.
EP0223369A3 (en) Pharmaceutical composition containing 2-(2-fluoro-4-biphenylyl)propionic acid or a salt thereof
HUP9903855A2 (hu) Orális adagolásra való valproesavat tartalmazó gyógyszerészeti mikrogömbök
GR3002513T3 (en) Use of glycofurol in liquefying pharmaceutical preparations for filling soft gelatin capsules
MX9804442A (es) Preparaciones de capsula blanda que contienen ciclosporina.
RU98115892A (ru) Фармацевтическая композиция, содержащая циклоспорин, способ получения мягких желатиновых капсул, способ лечения
AU2072088A (en) Agent containing salicylic acid for treating lepidosis
AR016629A1 (es) Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica.
YU49404B (sh) Nova smesa koja sadrži ciklosporin i poboljšani postupak za dobijanje mekih želatinskih kapsula koje sadrže ciklosporin
UA49004C2 (uk) Таблетка з уповільненим вивільненням, що містить мізоластин
JPS57146710A (en) Blood brain-barrier permeating ribosome-like microcapsule
EP0242554A3 (fr) Utilisation de la coenzyme-A comme agent anti-mutagène
GB1133845A (en) Pharmaceutical compositions comprising dextran and cellulose ethers
IT1254938B (it) Derivati otticamente attivi della n-imminoalchil-n'-((2-idrossi- 2-fenil-2-cicloesil)-etil)-piperazina
HUP0001478A2 (en) Eardrops for treatment of outer auditory meatus and process for producing thereof

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry